Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Now if we only knew what is in the memorandum of understanding

“all the information contained in our April 9, 2008 earnings release, which fully reflects the financial results of all transactions announced prior to the end of January 2008."

This was one of my favorites, because it's a wonderful example for telling one thing, while hiding the other:

1. "Transactions": the "grant" of rights of the MMP?

2. Financial results: the fee for this "grant"?

Thus, the earnings release reflected these financial results of that transaction, nothing more.

Perfect - and no problem with any financial/legal guidelines IMHO.

Let's see and (hopefully) be happy - glty

Share
New Message
Please login to post a reply